Transplant patients should have total body exams because they’re at higher risk for skin cancer, according to research in Jama Dermatology. The research looked at more than 400 organ recipients. Researchers said patients are at risk for new skin cancers because they’re on drugs to suppress the immune system.
A new study from researchers in the United Kingdom has suggested that drug side effects are under reported in medical journals. They said reporting medication issues is critical for doctors and patients to weigh the benefits and harms.
An experimental drug may prevent or reduce the progression of multiple sclerosis. A study in Neurology has shown that the drug laquinimod kept mice from developing MS.
Sources
1- JAMA Dermatology
2- University of York
3- Neurology
